New

Cannabis Pharmaceuticals Market

2021

Cannabis Pharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Epidiolex, Sativex); Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), and Geography

| Report Code: TIPRE00013755 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Cannabis Pharmaceuticals Market 2028 By Product, Distribution Channel, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

The use of cannabis in pharmaceuticals is estimated to transform the medical industry due to the properties of cannabis. The use of two components, such as CBD and THC have medicinal properties, which have been proved to treat health conditions such as epilepsy, schizophrenia, arthritis, multiple sclerosis, migraines. At present, across the world, more than 400 active and completed clinical trials are performed for cannabis-based medicinal products.

MARKET DYNAMICS

The cannabis pharmaceuticals market is anticipated to grow due to some driving factors, including the legalization of cannabis for medical applications, and increasing research and development for medical cannabis. The market is expected to have vital growth opportunities due to the growing adoption of cannabis for medical applications in Asian and Middle East countries, and rising product development by the pharmaceutical players.

MARKET SCOPE

The "Cannabis Pharmaceuticals Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cannabis pharmaceuticals market with detailed market segmentation by product, and distribution channel. The cannabis pharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cannabis pharmaceuticals market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The cannabis pharmaceuticals market is segmented on the basis of product, and distribution channel. Based on product, the market is segmented as epidiolex, and sativex. And based on distribution channel, the market is divided as hospital pharmacies, online pharmacies, and retail pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Cannabis pharmaceuticals market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cannabis pharmaceuticals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cannabis pharmaceuticals market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cannabis pharmaceuticals market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the cannabis pharmaceuticals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cannabis pharmaceuticals market are anticipated to have lucrative growth opportunities in the future with the rising demand for cannabis pharmaceuticals in the global market. Below mentioned is the list of few companies engaged in the cannabis pharmaceuticals market.
The report also includes the profiles of key players in cannabis pharmaceuticals market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbvie Inc.
  •  Insys Therapeutics, Inc.
  •  GW Pharmaceuticals
  •  Valeant Pharmaceuticals
  •  Tilray
  •  Cardiol Therapeutics
  •  Cure Pharmaceutical
  •  Zynerba Pharmaceuticals, Inc.
  •  Solvay Pharmaceuticals (Abbott)
  •  Indevus Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cannabis Pharmaceuticals Market - By Product
1.3.2 Cannabis Pharmaceuticals Market - By Distribution Channel
1.3.3 Cannabis Pharmaceuticals Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANNABIS PHARMACEUTICALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANNABIS PHARMACEUTICALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CANNABIS PHARMACEUTICALS MARKET - GLOBAL MARKET ANALYSIS
6.1. CANNABIS PHARMACEUTICALS - GLOBAL MARKET OVERVIEW
6.2. CANNABIS PHARMACEUTICALS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CANNABIS PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EPIDIOLEX
7.3.1. Overview
7.3.2. Epidiolex Market Forecast and Analysis
7.4. SATIVEX
7.4.1. Overview
7.4.2. Sativex Market Forecast and Analysis
8. CANNABIS PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Online Pharmacies Market Forecast and Analysis
8.5. RETAIL PHARMACIES
8.5.1. Overview
8.5.2. Retail Pharmacies Market Forecast and Analysis
9. CANNABIS PHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cannabis Pharmaceuticals Market Overview
9.1.2 North America Cannabis Pharmaceuticals Market Forecasts and Analysis
9.1.3 North America Cannabis Pharmaceuticals Market Forecasts and Analysis - By Product
9.1.4 North America Cannabis Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Cannabis Pharmaceuticals Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cannabis Pharmaceuticals Market
9.1.5.1.1 United States Cannabis Pharmaceuticals Market by Product
9.1.5.1.2 United States Cannabis Pharmaceuticals Market by Distribution Channel
9.1.5.2 Canada Cannabis Pharmaceuticals Market
9.1.5.2.1 Canada Cannabis Pharmaceuticals Market by Product
9.1.5.2.2 Canada Cannabis Pharmaceuticals Market by Distribution Channel
9.1.5.3 Mexico Cannabis Pharmaceuticals Market
9.1.5.3.1 Mexico Cannabis Pharmaceuticals Market by Product
9.1.5.3.2 Mexico Cannabis Pharmaceuticals Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Cannabis Pharmaceuticals Market Overview
9.2.2 Europe Cannabis Pharmaceuticals Market Forecasts and Analysis
9.2.3 Europe Cannabis Pharmaceuticals Market Forecasts and Analysis - By Product
9.2.4 Europe Cannabis Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Cannabis Pharmaceuticals Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cannabis Pharmaceuticals Market
9.2.5.1.1 Germany Cannabis Pharmaceuticals Market by Product
9.2.5.1.2 Germany Cannabis Pharmaceuticals Market by Distribution Channel
9.2.5.2 France Cannabis Pharmaceuticals Market
9.2.5.2.1 France Cannabis Pharmaceuticals Market by Product
9.2.5.2.2 France Cannabis Pharmaceuticals Market by Distribution Channel
9.2.5.3 Italy Cannabis Pharmaceuticals Market
9.2.5.3.1 Italy Cannabis Pharmaceuticals Market by Product
9.2.5.3.2 Italy Cannabis Pharmaceuticals Market by Distribution Channel
9.2.5.4 Spain Cannabis Pharmaceuticals Market
9.2.5.4.1 Spain Cannabis Pharmaceuticals Market by Product
9.2.5.4.2 Spain Cannabis Pharmaceuticals Market by Distribution Channel
9.2.5.5 United Kingdom Cannabis Pharmaceuticals Market
9.2.5.5.1 United Kingdom Cannabis Pharmaceuticals Market by Product
9.2.5.5.2 United Kingdom Cannabis Pharmaceuticals Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cannabis Pharmaceuticals Market Overview
9.3.2 Asia-Pacific Cannabis Pharmaceuticals Market Forecasts and Analysis
9.3.3 Asia-Pacific Cannabis Pharmaceuticals Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Cannabis Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Cannabis Pharmaceuticals Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cannabis Pharmaceuticals Market
9.3.5.1.1 Australia Cannabis Pharmaceuticals Market by Product
9.3.5.1.2 Australia Cannabis Pharmaceuticals Market by Distribution Channel
9.3.5.2 China Cannabis Pharmaceuticals Market
9.3.5.2.1 China Cannabis Pharmaceuticals Market by Product
9.3.5.2.2 China Cannabis Pharmaceuticals Market by Distribution Channel
9.3.5.3 India Cannabis Pharmaceuticals Market
9.3.5.3.1 India Cannabis Pharmaceuticals Market by Product
9.3.5.3.2 India Cannabis Pharmaceuticals Market by Distribution Channel
9.3.5.4 Japan Cannabis Pharmaceuticals Market
9.3.5.4.1 Japan Cannabis Pharmaceuticals Market by Product
9.3.5.4.2 Japan Cannabis Pharmaceuticals Market by Distribution Channel
9.3.5.5 South Korea Cannabis Pharmaceuticals Market
9.3.5.5.1 South Korea Cannabis Pharmaceuticals Market by Product
9.3.5.5.2 South Korea Cannabis Pharmaceuticals Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cannabis Pharmaceuticals Market Overview
9.4.2 Middle East and Africa Cannabis Pharmaceuticals Market Forecasts and Analysis
9.4.3 Middle East and Africa Cannabis Pharmaceuticals Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Cannabis Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Cannabis Pharmaceuticals Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cannabis Pharmaceuticals Market
9.4.5.1.1 South Africa Cannabis Pharmaceuticals Market by Product
9.4.5.1.2 South Africa Cannabis Pharmaceuticals Market by Distribution Channel
9.4.5.2 Saudi Arabia Cannabis Pharmaceuticals Market
9.4.5.2.1 Saudi Arabia Cannabis Pharmaceuticals Market by Product
9.4.5.2.2 Saudi Arabia Cannabis Pharmaceuticals Market by Distribution Channel
9.4.5.3 U.A.E Cannabis Pharmaceuticals Market
9.4.5.3.1 U.A.E Cannabis Pharmaceuticals Market by Product
9.4.5.3.2 U.A.E Cannabis Pharmaceuticals Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cannabis Pharmaceuticals Market Overview
9.5.2 South and Central America Cannabis Pharmaceuticals Market Forecasts and Analysis
9.5.3 South and Central America Cannabis Pharmaceuticals Market Forecasts and Analysis - By Product
9.5.4 South and Central America Cannabis Pharmaceuticals Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Cannabis Pharmaceuticals Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cannabis Pharmaceuticals Market
9.5.5.1.1 Brazil Cannabis Pharmaceuticals Market by Product
9.5.5.1.2 Brazil Cannabis Pharmaceuticals Market by Distribution Channel
9.5.5.2 Argentina Cannabis Pharmaceuticals Market
9.5.5.2.1 Argentina Cannabis Pharmaceuticals Market by Product
9.5.5.2.2 Argentina Cannabis Pharmaceuticals Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CANNABIS PHARMACEUTICALS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CANNABIS PHARMACEUTICALS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. INSYS THERAPEUTICS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GW PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. VALEANT PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TILRAY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CARDIOL THERAPEUTICS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CURE PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ZYNERBA PHARMACEUTICALS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SOLVAY PHARMACEUTICALS (ABBOTT)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INDEVUS PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbvie Inc.
2. Insys Therapeutics, Inc.
3. GW Pharmaceuticals
4. Valeant Pharmaceuticals
5. Tilray
6. Cardiol Therapeutics
7. Cure Pharmaceutical
8. Zynerba Pharmaceuticals, Inc.
9. Solvay Pharmaceuticals (Abbott)
10. Indevus Pharmaceuticals
TIPRE00013755
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.